{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T04:07:26Z","timestamp":1790222846209,"version":"4.1.0"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Chromatography B"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1016\/j.jchromb.2015.11.058","type":"journal-article","created":{"date-parts":[[2015,12,12]],"date-time":"2015-12-12T18:26:37Z","timestamp":1449944797000},"page":"138-143","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Development and validation of LC-ESI-MS\/MS method for analysis of moxifloxacin and levofloxacin in serum of multidrug-resistant tuberculosis patients: Potential application as therapeutic drug monitoring tool in medical diagnosis"],"prefix":"10.1016","volume":"1009-1010","author":[{"given":"Sung Joong","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kebede Taye","family":"Desta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seok Yong","family":"Eum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronique","family":"Dartois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Nae","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Won","family":"Bae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung Chul","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jchromb.2015.11.058_bib0005","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1021\/ac1029049","article-title":"High-sensitivity MALDI-MRM-MS imaging of moxifloxacin distribution in tuberculosis-infected rabbit lungs and granulomatous lesions","volume":"83","author":"Prideaux","year":"2011","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jchromb.2015.11.058_bib0010","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1164\/rccm.201303-0604OC","article-title":"Comparison of levofloxacin versus moxifloxacin for multidrug-resistant tuberculosis","volume":"188","author":"Koh","year":"2013","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.jchromb.2015.11.058_bib0015","unstructured":"World Health Organization fact sheet (No. 104) on tuberculosis. Update, March 2015. http:\/\/www.who.int\/mediacentre\/factsheets\/fs104\/en\/(accessed: 17.08.15.)."},{"key":"10.1016\/j.jchromb.2015.11.058_bib0020","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1111\/j.1440-1843.2006.00948.x","article-title":"Cost of treatment for multidrug-resistant tuberculosis in South Korea","volume":"11","author":"Y.A. Kang","year":"2006","journal-title":"Respirology"},{"key":"10.1016\/j.jchromb.2015.11.058_bib0025","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2165\/00003495-200161010-00002","article-title":"The role of floroquinolones in tuberculosis today","volume":"61","author":"Berning","year":"2001","journal-title":"Drugs"},{"key":"10.1016\/j.jchromb.2015.11.058_bib0030","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1128\/AAC.01036-07","article-title":"Population pharmacokinetics of levofloxacin, gatifloxacin, and moxifloxacin in adults with pulmonary tuberculosis","volume":"52","author":"Charles","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jchromb.2015.11.058_bib0035","doi-asserted-by":"crossref","unstructured":"American thoracic society\/centers for disease control and prevention\/infectious diseases society of America: treatment of tuberculosis, Am. J. Respir. Crit. Care Med., 167 (2003) 603-662.","DOI":"10.1164\/rccm.167.4.603"},{"key":"10.1016\/j.jchromb.2015.11.058_bib0040","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1378\/chest.124.4.1476","article-title":"Comparative roles of levofloxacin and ofloxacin in the treatment of multidrug-resistant tuberculosis: preliminary results of a retrospective study from Hong Kong","volume":"124","author":"Yew","year":"2003","journal-title":"Chest"},{"key":"10.1016\/j.jchromb.2015.11.058_bib0045","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ijantimicag.2013.02.019","article-title":"Comparative roles of moxifloxacin and levofloxacin in the treatment of pulmonary multidrug-resistant tuberculosis: a retrospective study","volume":"42","author":"Jianga","year":"2013","journal-title":"Int. J. Antimicrob. Ag."},{"key":"10.1016\/j.jchromb.2015.11.058_bib0050","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3904\/kjim.2011.26.2.153","article-title":"Retrospective comparison of levofloxacin and moxifloxacin on multidrug-resistant tuberculosis treatment outcomes","volume":"26","author":"Lee","year":"2011","journal-title":"Korean J. Intern. Med."},{"key":"10.1016\/j.jchromb.2015.11.058_bib0055","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0378-4347(00)00166-3","article-title":"Determination of moxifloxacin (BAY 12-8039) in plasma and lung tissue by high-performance liquid chromatography with ultraviolet detection using a fully automated extraction method with a new polymeric cartridge","volume":"742","author":"Lemoine","year":"2000","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jchromb.2015.11.058_bib0060","doi-asserted-by":"crossref","first-page":"3437","DOI":"10.1016\/j.jchromb.2010.10.024","article-title":"High performance liquid chromatography assay with ultraviolet detection for moxifloxacin: validation and application to a pharmacokinetic study in Chinese volunteers","volume":"878","author":"Yu","year":"2010","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jchromb.2015.11.058_bib0065","first-page":"247","article-title":"Development and validation of HPLC-UV method for the estimation of levofloxacin in human plasma","volume":"3","author":"Kumar","year":"2011","journal-title":"Intern. J. Pharm. Pharm. Sci."},{"key":"10.1016\/j.jchromb.2015.11.058_bib0070","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jchromb.2006.07.001","article-title":"Optimization and validation of the direct HPLC method for the determination of moxifloxacin in plasma","volume":"844","author":"LD","year":"2006","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jchromb.2015.11.058_bib0075","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.jchromb.2009.02.039","article-title":"Pharmacokinetics of fluoroquinolones in critical care patients: a bio-analytical HPLC method for the simultaneous quantification of ofloxacin, ciprofloxacin and moxifloxacin in human plasma","volume":"877","author":"Julie","year":"2009","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jchromb.2015.11.058_bib0080","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/j.jchromb.2009.02.042","article-title":"Simple and rapid liquid chromatography method for determination of moxifloxacin in plasma","volume":"877","author":"Kumar","year":"2009","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jchromb.2015.11.058_bib0085","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1016\/j.jpba.2006.02.010","article-title":"Validation of a levofloxacin HPLC assay in plasma and dialysate for pharmacokinetic studies","volume":"41","author":"Siewert","year":"2006","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jchromb.2015.11.058_bib0090","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1093\/jat\/34.3.135","article-title":"Determination of moxifloxacin in human plasma, plasma ultrafiltrate, and cerebrospinal fluid by a rapid and simple liquid chromatography-tandem mass spectrometry method","volume":"34","author":"Pranger","year":"2010","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.jchromb.2015.11.058_bib0095","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.jchromb.2011.03.017","article-title":"Determination of moxifloxacin in dried blood spots using LC\u2013MS\/MS and the impact of the hematocrit and blood volume","volume":"879","author":"Vu","year":"2011","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jchromb.2015.11.058_bib0100","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/S0731-7085(02)00393-X","article-title":"Determination of moxifloxacin in human plasma by liquid chromatography electrospray ionization tandem mass spectrometry","volume":"30","author":"Vishwanathan","year":"2002","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jchromb.2015.11.058_bib0105","first-page":"19","article-title":"Principles and applications of liquid chromatography-mass spectrometry in clinical biochemistry: a review","volume":"30","author":"Pitt","year":"2009","journal-title":"Clin. Biochem. Rev."},{"key":"10.1016\/j.jchromb.2015.11.058_bib0110","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1021\/ac020361s","article-title":"Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS\/MS","volume":"75","author":"Matuszewski","year":"2003","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jchromb.2015.11.058_bib0115","unstructured":"US Department of Health and Human Services, food and drug administration, center for drug evaluation and research (CDER), center for veterinary medicine (CVM): guidance for industry, bio-analytical method validation, May 2001, Available from http:\/\/www.fda.gov\/cder\/guidance\/index.htm (accessed: 12.08.15.)."},{"key":"10.1016\/j.jchromb.2015.11.058_bib0120","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0021-9673(02)01536-4","volume":"987","author":"Shabir","year":"2003","journal-title":"J. Chromatogr. A"}],"container-title":["Journal of Chromatography B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S157002321530310X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S157002321530310X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,17]],"date-time":"2018-09-17T02:50:47Z","timestamp":1537152647000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S157002321530310X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":24,"alternative-id":["S157002321530310X"],"URL":"https:\/\/doi.org\/10.1016\/j.jchromb.2015.11.058","relation":{},"ISSN":["1570-0232"],"issn-type":[{"value":"1570-0232","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development and validation of LC-ESI-MS\/MS method for analysis of moxifloxacin and levofloxacin in serum of multidrug-resistant tuberculosis patients: Potential application as therapeutic drug monitoring tool in medical diagnosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Chromatography B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jchromb.2015.11.058","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}